Archive for Cancer Treatment

Cancer Treatment and Cancer Care(CTCA) Job opportunities

There are many ways to beat cancer, is the belief at Cancer Treatment Centers of America, CTCA. They believe that there are hundreds of ways to counteract the disease. For about 30 years of operation, CTCA has a dedication to discovering the best combination of customized treatments for cancer for its patients. A committed staff of surgeons, specialists and oncologists offer advanced treatment for cancer such as operative and safer radiotherapy, more particular surgical options and innovative targeted drug cures.Cancer Treatment Centers of America at Eastern Regional Medical Center in Philadelphia is recruiting a Nocturnist. The preferred candidate should have experience and training with several cancer categories. The hired candidate will take care of grown-up cancer inpatients and attend to the evening inpatient level on a 7-nights-off, 7-nights-on timetable. To qualify for this job candidates must have: DO, MD or external degree equivalent, entitlement for Pennsylvania medical warrant and should be a Board eligible in Internal Medicine.

Cancer Treatment Centers of America invites an interested candidate to apply for the position of an Operator, Switchboard personnel. To qualify for the post mentioned above, one should have a Minimum secondary school diploma or equivalent, robust problem-solving skills, outstanding verbal and written communications expertise, one year minimum of telephone exchange experience and should be a self-motivated and detail accommodator. Job applications are open for the position of Vice President, Growth-Patient Engagement. The selected candidate will be taking tasks of delivering the monthly budget and competent new patient additional figures to the five Cancer Treatment Centers of America in the medical centers of his administrative region. Qualifications for this position include a bachelor’s Degree (MHA, MBA) is strongly needed, an official leadership in using analytics and statistics in an operational problem-solving experience of not less than five years. The preferred candidate is also expected to have demonstrated not less than fifteen years of experience in contact center operations and increasing sales.

Applications for a Dispatcher at Cancer Treatment Centers of America are open. The duties of a Dispatcher includes Preparing patient and guest substantial transportation to and from the hotels, airport, and appointments. He also deals with all scheduled patients’ activities that are sponsored by Cancer Treatment Centers of America. To qualify, one requires to have not less than three years’ experience in driving, three and above years’ experience in customer care services and must have graduated in high school. The candidate Should also pass the Department of Transportation practical test, possess a valid driver’s license for the State of Georgia and a valid Commercial Driver’s License for the State of Georgia having a Passenger Endorsement. Ability to speak fluent Spanish will be an added advantage.Cancer Treatment Centers of America value talent and teamwork. They also consider candidates with a thirst for improvement since the organization believes in creativity and problem solving for its clients.

 

Clay Siegall Directs Seattle Genetics

Seattle Genetics was founded by Clay Siegall in 1998. He acts as the company’s Chairman of the Board and Chief Executive Officer. He is a career scientist who is passionate about cancer research. He is an emblem of scientific innovation within the cancer research community, and he has created new drug development practices that have been employed in rigorous scientific research on cancer. Seattle Genetics is an industry leader in the development of antibody drug conjugates. It has received approval from the FDA for its products and has put the famous drug known as ADCETRIS on the market. Under Clay Siegall’s leadership, Seattle Genetics formed a strategic partnership with Takeda Pharmaceutical Company. This partnership has made it possible for Seattle Genetics to help patients in more than 60 countries around the world. The company continues to innovate new products for the treatment of cancer and is currently developing new antibody-drug conjugate products.

Clay Siegall has driven Seattle Genetics to enter into various strategic licenses for its proprietary cancer treatment technology. AbbVie, GlaxoSmithKline, Pfizer, and Genentech are some of the companies it works with. More than $325 million have been generated from these licenses at this point in time. This is because Clay’s company has developed over 20 proprietary technologies in the area of cancer research. Investors see great potential in Seattle Genetics and they have invested more than a billion dollars in the company.

Clay Siegall began his education at the University of Maryland where he earned a B.S. in Zoology. He loved science and wanted to learn more about how he could use it to help people, so he went on to George Washington University where he earned a Ph.D. in Genetics. Since that time, Clay has continued to absorb interdisciplinary knowledge that would help him in the fight against cancer. His contributions to science were recognized by the University of Maryland in 2013. It awarded him the prize for Alumnus of the Year for Computer, Math, and Natural Sciences.